As migration of inflammatory cells across the BBB represents a pathological hallmark of MS, we analysed the effects of the CD40-TRAF6-blocking SMI on monocyte migration across an in vitro BBB [31]. The gene discussed is TRAF6; the disease is myeloid sarcoma.